Literature DB >> 3865934

Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.

K Matsuki, T Juji, K Tokunaga, T Naohara, M Satake, Y Honda.   

Abstract

In order to deduce the predominant haplotypes in Japanese narcoleptics, we have studied a total of 111 Japanese patients with narcolepsy and six multiple-case families for HLA class I and class II antigens, and for class III HLA-linked complement markers. In Japanese narcoleptics, the most frequent haplotypes were B35-DR2, B15-DR2, and B51-DR2. These haplotypes were rare in normal Japanese population. In contrast, the most frequent haplotype of HLA-DR2 in normal Japanese, A24-C blank-Bw52-C4A*2 B*Q0-BF *S-C2*C-DR2-DQw1, had a decreased frequency to one-third of the normal controls. Haplotypes B35-DR2, B15-DR2, and B51-DR2, which were more frequent among Japanese narcoleptics, were different from the haplotype found more frequently among Caucasoid narcoleptics, A3-Cw7-B7-DR2-DQw1. Haplotype analysis on six families showed that B35-DR2 and other rare haplotypes in normal Japanese were associated with narcolepsy. There were four cases without any signs of narcolepsy among 19 subjects with the disease susceptibility haplotypes. This finding suggests an incomplete penetrance of hypersomnia. Haplotype analysis of family members was also useful for the early detection of the high risk children to narcolepsy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3865934      PMCID: PMC424312          DOI: 10.1172/JCI112211

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  A counting method of maximum likelihood for estimating haplotype frequency in the HL-A system.

Authors:  N Yasuda; K Tsuji
Journal:  Jinrui Idengaku Zasshi       Date:  1975-06

2.  A family study of 50 REM narcoleptics.

Authors:  S Kessler; C Guilleminault; W Dement
Journal:  Acta Neurol Scand       Date:  1974       Impact factor: 3.209

3.  Heredofamilial aspects of narcolepsy and hypersomnia.

Authors:  S Nevsimalova-Brůhova; B Roth
Journal:  Schweiz Arch Neurol Neurochir Psychiatr       Date:  1972

4.  Possible association between HLA-B7 and narcolepsy.

Authors:  J Seignalet; M Billiard
Journal:  Tissue Antigens       Date:  1984-03

5.  HL-A haplotypes of 32 diseases.

Authors:  P I Terasaki; M R Mickey
Journal:  Transplant Rev       Date:  1975

6.  Statement on the nomenclature of human C4 allotypes.

Authors:  G Mauff; C A Alper; Z Awdeh; J R Batchelor; J Bertrams; G Bruun-Petersen; R L Dawkins; P Démant; J Edwards; H Grosse-Wilde; G Hauptmann; P Klouda; L Lamm; E Mollenhauer; C Nerl; B Olaisen; G O'Neill; C Rittner; M H Roos; V Skanes; P Teisberg; L Wells
Journal:  Immunobiology       Date:  1983-03       Impact factor: 3.144

7.  HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive.

Authors:  T Juji; M Satake; Y Honda; Y Doi
Journal:  Tissue Antigens       Date:  1984-11

8.  Six HLA-D region alpha-chain genes on human chromosome 6: polymorphisms and associations of DC alpha-related sequences with DR types.

Authors:  R S Spielman; J Lee; W F Bodmer; J G Bodmer; J Trowsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Genetic polymorphism of the complement C2 in Japanese.

Authors:  K Tokunaga; C Araki; T Juji; K Omoto
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

10.  Two distinct HLA-D specificities (DHO and Dw2) in linkage with HLA-DRw2 as defined in white and Japanese populations.

Authors:  N L Reinsmoen; T Sasazuki; H Kaneoka; N Ohta; H J Noreen; L J Greenberg; J H Kersey
Journal:  Transplant Proc       Date:  1978-12       Impact factor: 1.066

View more
  18 in total

1.  The narcolepsy-associated DRw15,DQw6,Dw2 haplotype has no unique HLA-DQA or -DQB restriction fragments and does not extend to the HLA-DP subregion.

Authors:  O Olerup; M Schaffer; J Hillert; C Sachs
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  HLA-DQ beta chain DNA restriction fragments can differentiate between healthy and narcoleptic individuals with HLA-DR2.

Authors:  H Inoko; A Ando; K Tsuji; K Matsuki; T Juji; Y Honda
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  An approach based on a genome-wide association study reveals candidate loci for narcolepsy.

Authors:  Mihoko Shimada; Taku Miyagawa; Minae Kawashima; Susumu Tanaka; Yutaka Honda; Makoto Honda; Katsushi Tokunaga
Journal:  Hum Genet       Date:  2010-07-31       Impact factor: 4.132

4.  Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity.

Authors:  Mehdi Tafti; Gert J Lammers; Yves Dauvilliers; Sebastiaan Overeem; Geert Mayer; Jacek Nowak; Corinne Pfister; Valérie Dubois; Jean-François Eliaou; Hans-Peter Eberhard; Roland Liblau; Aleksandra Wierzbicka; Peter Geisler; Claudio L Bassetti; Johannes Mathis; Michel Lecendreux; Ramin Khatami; Raphaël Heinzer; José Haba-Rubio; Eva Feketeova; Christian R Baumann; Zoltán Kutalik; Jean-Marie Tiercy
Journal:  Sleep       Date:  2016-03-01       Impact factor: 5.849

5.  Taq I-generated HLA-DQ alpha polymorphism in Japanese patients with narcolepsy.

Authors:  K Matsuki; H Maeda; T Juji; H Inoko; A Ando; K Tsuji; Y Honda
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region.

Authors:  F Szafer; C Brautbar; E Tzfoni; G Frankel; L Sherman; I Cohen; S Hacham-Zadeh; W Aberer; G Tappeiner; K Holubar
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

7.  Genomewide association analysis of human narcolepsy and a new resistance gene.

Authors:  Minae Kawashima; Gen Tamiya; Akira Oka; Hirohiko Hohjoh; Takeo Juji; Takashi Ebisawa; Yutaka Honda; Hidetoshi Inoko; Katsushi Tokunaga
Journal:  Am J Hum Genet       Date:  2006-06-13       Impact factor: 11.025

8.  Evaluation of polygenic risks for narcolepsy and essential hypersomnia.

Authors:  Maria Yamasaki; Taku Miyagawa; Hiromi Toyoda; Seik-Soon Khor; Xiaoxi Liu; Hitoshi Kuwabara; Yukiko Kano; Takafumi Shimada; Toshiro Sugiyama; Hisami Nishida; Nagisa Sugaya; Mamoru Tochigi; Takeshi Otowa; Yuji Okazaki; Hisanobu Kaiya; Yoshiya Kawamura; Akinori Miyashita; Ryozo Kuwano; Kiyoto Kasai; Hisashi Tanii; Tsukasa Sasaki; Yutaka Honda; Makoto Honda; Katsushi Tokunaga
Journal:  J Hum Genet       Date:  2016-06-16       Impact factor: 3.172

Review 9.  Benefits and risks of pharmacotherapy for narcolepsy.

Authors:  Merrill M Mitler; Roza Hayduk
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

10.  Treatment of narcolepsy with methamphetamine.

Authors:  M M Mitler; R Hajdukovic; M K Erman
Journal:  Sleep       Date:  1993-06       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.